Back

Deaths and vascular outcomes with non-vitamin k oral anticoagulants versus warfarin in patients with heart failure in the food and drug administration adverse event reporting system

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic heart failure – Epidemiology, prognosis, outcome Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Thomas Gero Von Lueder

Oslo University Hospital Rikshospitalet, Oslo (Norway)

16 More presentations in this session

Presentation thumbnail
The association between renin-angiotensin-aldosterone system inhibitors dose reduction and risk of mortality and major adverse cardiovascular events in heart failure patients
Mr D. Ayoubkhani (Cardiff, GB)
Abstract Slides
Presentation thumbnail
Longitudinal changes in troponin concentrations from mid- to late-life and left ventricular structure and function in late-life: The Atherosclerosis Risk in Community Study
Professor P. Myhre (Oslo, NO)
Abstract Slides
Presentation thumbnail
One year follow-up of heart failure patients: role of the new TNM-like staging system
Doctor M. Alfarano (Rome, IT)
Abstract
Presentation thumbnail
Incidence and prevalence of light chain amyloidosis: a population-based study
Miss S. Duhamel (Bron, FR)
Abstract
Presentation thumbnail
Prediction of sudden death in outpatients with heart failure: a bio-clinical approach.
Doctor J. Lupon (Barcelona, ES)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Chronic heart failure – Epidemiology, prognosis, outcome

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources